Content about Autoimmune diseases

July 22, 2011

A panel of experts at the Food and Drug Administration has recommended that the agency approve a drug made by Johnson & Johnson as a treatment for ulcerative colitis in children.

HORSHAM, Pa. — A panel of experts at the Food and Drug Administration has recommended that the agency approve a drug made by Johnson & Johnson as a treatment for ulcerative colitis in children.

July 18, 2011

The National Eczema Association, a nonprofit organization devoted to improving the health and quality of life for those living with eczema, has awarded four MD Moms products with its Seal of Acceptance, which means that the products have been evaluated to determine that they do not contain ingredients or contents that are known to be unsuitable for use by those with eczema or sensitive skin conditions.

LOS ANGELES — The National Eczema Association, a nonprofit organization devoted to improving the health and quality of life for those living with eczema, has awarded four MD Moms products with its Seal of Acceptance, which means that the products have been evaluated to determine that they do not contain ingredients or contents that are known to be unsuitable for use by those with eczema or sensitive skin conditions.

July 18, 2011

The Food and Drug Administration has approved a drug made by Shire for treating ulcerative colitis, the British drug maker said Monday.

PHILADELPHIA — The Food and Drug Administration has approved a drug made by Shire for treating ulcerative colitis, the British drug maker said Monday.

Shire announced the approval of Lialda (mesalamine) delayed-release tablets for the maintenance of remission in patients with the disease.

The drug was already approved for inducing remission in patients with ulcerative colitis, an inflammatory disease that affects the colon and causes chronic inflammation, sores and ulcers.

July 11, 2011

Upsher-Smith Labs has launched a topical medication for itching and inflammation of the skin resulting from such conditions as psoriasis and atopic dermatitis, the company said Monday.

MAPLE GROVE, Minn. — Upsher-Smith Labs has launched a topical medication for itching and inflammation of the skin resulting from such conditions as psoriasis and atopic dermatitis, the company said Monday.

Upsher-Smith announced the launch of Trianex (triamcinolone acetonide) ointment, which the company described as a prescription topical corticosteroid that offers the feel of a cream and the strength of an ointment.

July 7, 2011

+MD Wellness showcased its line of Gel Spa Socks that help moisturize and heal conditions like eczema, psoriasis and cracked, dry skin. Selling for a suggested $13.99, the gel is a thermoplastic rubber that does not disintegrate with use like many silicone products.

+MD Wellness showcased its line of Gel Spa Socks that help moisturize and heal conditions like eczema, psoriasis and cracked, dry skin. Selling for a suggested $13.99, the gel is a thermoplastic rubber that does not disintegrate with use like many silicone products. The TPR gel also is hypoallergenic, absorbs shock and is washable and reusable. The yarn content in the body of the sock is 80% cotton, 18% polyester and 2% spandex. The socks are available in blue and pink colors.

June 30, 2011

Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

MISSISSAUGA, Ontario — Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

Valeant said it would buy rights for the eczema drug Elidel (pimecrolimus) and the cold sore drug Xerese (acyclovir and hydrocortisone) for the United States, Canada and Mexico. Valeant said, however, that Xerese has not yet received regulatory approval in Canada.

June 24, 2011

Patients with inflammatory conditions may have lower rates of diabetes if they take drugs commonly used to treat arthritis, according to a new study published in the Journal of the American Medical Association.

NEW YORK — Patients with inflammatory conditions may have lower rates of diabetes if they take drugs commonly used to treat arthritis, according to a new study published in the Journal of the American Medical Association.

The study, conducted by researchers at Brigham and Women’s Hospital in Boston, examined nearly 14,000 patients with rheumatoid arthritis and psoriasis who took disease-modifying anthrheumatic drugs. Patients who have these diseases have significantly increased risk of developing cardiovascular disease and diabetes.

June 13, 2011

More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

WASHINGTON — More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

The Pharmaceutical Research and Manufacturers of America said Monday that the country’s drug makers were developing 263 medicines for skin diseases that affect more than one-third of the U.S population. A study by the Lewin Group found that the annual total cost of skin diseases was $39.3 billion in 2005.

June 10, 2011

The Juvenile Diabetes Research Foundation and Selecta Biosciences have established a research collaboration to develop vaccines for Type 1 diabetes, also known as juvenile diabetes.

NEW YORK and WATERTOWN, Mass. — The Juvenile Diabetes Research Foundation and Selecta Biosciences have established a research collaboration to develop vaccines for Type 1 diabetes, also known as juvenile diabetes.

Through the collaboration, JDRF will provide "milestone-based financial support and expertise" to Selecta, which ultimately would apply its vaccine technology to create a vaccine that would halt or prevent the autoimmune response that causes Type 1 diabetes.

May 26, 2011

A milk formula for babies made by Gerber Products can reduce the risk of atopic dermatitis, and Gerber has the Food and Drug Administration’s permission to say so.

FLORHAM PARK, N.J. — A milk formula for babies made by Gerber Products can reduce the risk of atopic dermatitis, and Gerber has the Food and Drug Administration’s permission to say so.

Gerber said Thursday that its Good Start milk-based formulas were the first and only infant formulas to meet the FDA’s criteria for a qualified health claim. The partially hydrolyzed formula may reduce a baby’s risk of developing atopic dermatitis in the first year.

May 25, 2011

Introducing a gluten-free diet to an infant may not reduce its risk of developing Type 1 diabetes, according to a new study published in Diabetes Care.

NEW YORK — Introducing a gluten-free diet to an infant may not reduce its risk of developing Type 1 diabetes, according to a new study published in Diabetes Care.

German researchers analyzed data pooled from 150 infants with a first-degree family history of Type 1 diabetes and randomly exposed them to gluten at the age of 6 months (control group) or 12 months (late-exposure group). The infants then were followed until 3 years of age (and annually thereafter for safety purposes).

May 18, 2011

Regional supermarket chain Fresh & Easy said that it is augmenting its gluten-free products range and will highlight the new offerings in stores through additional displays.

EL SEGUNDO, Calif. — Regional supermarket chain Fresh & Easy said that it is augmenting its gluten-free products range and will highlight the new offerings in stores through additional displays.

The company said it has added 15 to 30 new gluten-free items to its stores. Fresh & Easy currently boasts more than 500 products that do not contain naturally occurring gluten ingredients.

May 13, 2011

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

WASHINGTON — More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

May 11, 2011

Consumers with celiac disease and gluten sensitivity now can add a popular cereal brand to their diet.

BATTLE CREEK, Mich. — Consumers with celiac disease and gluten sensitivity now can add a popular cereal brand to their diet.

Kellogg's said that its Rice Krispies brand will tout a gluten-free version, which will hit store shelves in June, carrying the same suggested retail price as original Rice Krispies. Each serving of the new gluten-free cereal contains 120 calories, less than 1 g of sugar, 1 g each of fat and fiber, 3 g of protein and 190 mg of sodium.

The introduction marks Kellogg's first-ever gluten-free cereal.

April 22, 2011

Many children with Type 1 diabetes have other autoimmune disorders as well, according to published reports.

NEW YORK — Many children with Type 1 diabetes have other autoimmune disorders as well, according to published reports.

Citing findings in a recent study of nearly 500 children published in the journal Diabetes Care, Reuters reported that one-third of children with the disease — an autoimmune disorder in which the immune system attacks the cells of the pancreas — also have such disorders as celiac disease, autoimmune thyroid disease and a disorder of the adrenal glands called Addison’s disease.

April 12, 2011

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

JERUSALEM — An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

March 3, 2011

The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

BRIDGEWATER, N.J. — The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

The FDA approved indomethacin extended-release capsules in the 75-mg strength. The drug is used to treat pain associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, bursitis and tendonitis.

March 3, 2011

The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.

DARMSTADT, Germany — The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.

February 22, 2011

Prasco Labs will distribute an authorized generic version of an ulcerative colitis treatment made by Shire in the event that any other company steps forward to file an abbreviated new drug application for the drug.

CINCINNATI — Prasco Labs will distribute an authorized generic version of an ulcerative colitis treatment made by Shire in the event that any other company steps forward to file an abbreviated new drug application for the drug.

February 4, 2011

A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

THOUSAND OAKS, Calif. — A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

Amgen and Pfizer on Friday announced the results of the phase-4 study of Enbrel (etanercept), in patients with moderate to severe plaque psoriasis with scaling on the scalp, also known as scalp involvement. Data from the trial will be presented Friday at the 69th annual meeting of the American Academy of Dermatology in New Orleans.

February 3, 2011

Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.

INDIANAPOLIS — Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.

The two announced Thursday that ideas included finding ways to grow new insulin-producing cells within a person’s body. Type 1 diabetes, also known as juvenile diabetes, is an autoimmune disease in which the immune system attacks beta cells, the cells that allow the body to produce insulin. As many as 3 million people in the United States have Type 1 diabetes.

February 2, 2011

Gluten-free products, once regarded as a niche category, have become mainstream, according to new research by Packaged Facts.

NEW YORK — Gluten-free products, once regarded as a niche category, have become mainstream, according to new research by Packaged Facts.

The Packaged Facts report, "Gluten-Free Foods and Beverages in the U.S., Third Edition," found that the gluten-free food and beverage market reached an estimated $2.6 billion in retail sales in 2010. Packaged Facts added that it projects the gluten-free products market will grow to $6 billion in 2015.

January 24, 2011

“The View” co-host Elisabeth Hasselbeck aims to raise awareness around celiac disease, coupling her recently published book, "The G-Free Diet: A Gluten-Free Survival Guide," with a line of gluten-free, meal-replacement bars called Nogii in partnership with Europa Sports Products.

SAN ANTONIO — “The View” co-host Elisabeth Hasselbeck aims to raise awareness around celiac disease, coupling her recently published book, "The G-Free Diet: A Gluten-Free Survival Guide," with a line of gluten-free, meal-replacement bars called Nogii in partnership with Europa Sports Products.

January 24, 2011

Advanced Vision Research on Monday announced results from a pilot trial published in the journal Cornea that demonstrated a reduction in dry-eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears Nutrition, an optimized blend of omega-3 oils.

WOBURN, Mass. — Advanced Vision Research on Monday announced results from a pilot trial published in the journal Cornea that demonstrated a reduction in dry-eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears Nutrition, an optimized blend of omega-3 oils.

Almost 3-in-4 symptomatic dry-eye patients who received the omega-3 supplement reported having no symptoms of dry eye after 90 days. In the placebo group, only 7% had a complete reduction of symptoms.

January 11, 2011

Bayer HealthCare Pharmaceuticals sought to reassure healthcare professionals and their patients that a recall of alcohol prep pads distributed with its multiple sclerosis drug did not affect the drug itself.

WAYNE, N.J. — Bayer HealthCare Pharmaceuticals sought to reassure healthcare professionals and their patients that a recall of alcohol prep pads distributed with its multiple sclerosis drug did not affect the drug itself.

The drug maker’s MS treatment Betaseron (interferon beta-1b) is distributed with prep pads made by Triad Group, which recently staged a recall of prep products due to potential contamination with Bacillus cereus bacteria, which would lead to life-threatening infections.